Superfund Research Program

Journal of Advanced Research (impact factor: 10.479)

2023

• Leuillier M, Duflot T, Menoret S, Messaoudi H, Djerada Z, Groussard D, Denis RG, Chevalier L, Karoui A, Panthu B, Thiebaut P, Schmitz-Afonso I, Nobis S, Campart C, Henry T, Sautreuil C, Luquet SH, Beseme O, Feliu C, Peyret H, Nicol L, Henry J, Renet S, Mulder P, Wan D, Tesson L, Heslan J, Duche A, Jacques S, Ziegler F, Brunel V, Rautureau GJ, Monteil C, do Rego J, do Rego J, Afonso C, Hammock BD, Madec A, Pinet F, Richard V, Anegon I, Guignabert C, Morisseau C, Bellien J. 2023. CRISPR/Cas9-mediated inactivation of the phosphatase activity of soluble epoxide hydrolase prevents obesity and cardiac ischemic injury. J. Adv. Res 43:163-174. doi:10.1016/j.jare.2022.03.004 PMID:36585106 PMCID:PMC9811321

2019

• Mohamed HT, Gadalla R, El-Husseiny N, Hassan H, Wang Z, Ibrahim SA, El-Shinawi M, Sherr DH, Mohamed M. 2019. Inflammatory breast cancer: Activation of the aryl hydrocarbon receptor and its target CYP1B1 correlates closely with Wnt5a/b-beta-catenin signalling, the stem cell phenotype and disease progression. J. Adv. Res 16:75-86. doi:10.1016/j.jare.2018.11.006 PMID:30899591 PMCID:PMC6413307
• . 2019. Inflammatory breast cancer: Activation of the aryl hydrocarbon receptor and its target CYP1B1 correlates closely with Wnt5a/b-beta-catenin signalling, the stem cell phenotype and disease progression. J. Adv. Res 16:75-86. doi:10.1016